Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
Antioxidants · 24.06.2025 · 14 (7) · 774
DOI: 10.3390/antiox14070774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 24.06.2025. Verfasst von Mohammed Alrouji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ajman University, King Khalid University, Shaqra University.
Themen: Demenz
Abstract (Originalsprache)
Aging is a key risk factor for neurodegenerative disorders and is associated with widespread systemic and brain-specific changes. Alzheimer’s disease (AD), a progressive and irreversible brain disorder, primarily affects older adults and leads to a gradual decline in cognitive function. The underlying disease mechanisms often begin years before clinical symptoms appear, limiting the effectiveness of current treatments. Several factors linked to aging—including inflammation, oxidative stress, impaired metabolism, and protein aggregation—contribute to the onset and progression of AD. A central feature of AD is the abnormal accumulation of amyloid beta (Aβ) and tau, a microtubule-associated protein, driven by post-translational modifications such as acetylation and hyperphosphorylation. These modifications lead to structural changes in tau, promoting the formation of neurofibrillary tangles (NFTs), which are more closely associated with cognitive decline than Aβ plaques. Interestingly, tau accumulation and the resulting cognitive impairments are often observed in aged individuals without Aβ deposition, highlighting tauopathy as a distinct contributor to age-related cognitive decline. This review focuses on new developments in therapeutic approaches that target oxidative stress, protein aggregation, and neuroinflammation, and our current understanding of the molecular pathways relating aging and tau pathology in AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha 62521, Saudi Arabia.
- Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
ORCID-Profile: Mohammed Alrouji, Syed Tasqeeruddin, Anas Shamsi
Förderung
- Ajman University
- King Khalid University
- Shaqra University
Zitieren
APA
Alrouji, M., Alshammari, M. S., Tasqeeruddin, S., & Shamsi, A. (2025). Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives. Antioxidants, 14(7), 774. https://doi.org/10.3390/antiox14070774
Vancouver
Alrouji M, Alshammari MS, Tasqeeruddin S, Shamsi A. Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives. Antioxidants. 2025;14(7):774. doi:10.3390/antiox14070774
BibTeX
@article{Alrouji2025,
author = {Alrouji, Mohammed and Alshammari, Mohammed S and Tasqeeruddin, Syed and Shamsi, Anas},
title = {Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {7},
pages = {774},
doi = {10.3390/antiox14070774}
}
EUVIMED